Survival Outcomes of Screening with Breast MRI in Women at Elevated Risk of Breast Cancer.
MRI
mammography
screening
survival breast cancer
Journal
Journal of breast imaging
ISSN: 2631-6129
Titre abrégé: J Breast Imaging
Pays: United States
ID NLM: 101752190
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
07
08
2019
accepted:
01
01
2019
entrez:
15
2
2020
pubmed:
15
2
2020
medline:
15
2
2020
Statut:
ppublish
Résumé
To determine survival outcomes in women with breast cancer detected at combined screening with breast MRI and mammography versus screening mammography alone. This is an institutional review board-approved retrospective study, and the need for informed consent was waived. A total of 3002 women with an increased risk of breast cancer were screened between 2001 and 2004. Of the 3002 women, 1534 (51.1%) had 2780 combined screenings (MRI and mammography) and 1468 (48.9%) had 4811 mammography-only screenings. The The overall cancer detection rate was significantly higher in the MRI plus mammography group compared with the mammography-only group (1.4% [40 of 2780] vs 0.5% [23 of 4811]; Combined screening with MRI and mammography in women at elevated risk of breast cancer improves cancer detection and overall survival.
Identifiants
pubmed: 32055796
doi: 10.1093/jbi/wbz083
pii: wbz083
pmc: PMC6999769
doi:
Types de publication
Journal Article
Langues
eng
Pagination
29-35Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Informations de copyright
© Society of Breast Imaging 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Ann Intern Med. 2008 May 6;148(9):671-9
pubmed: 18458280
J Clin Oncol. 2005 Nov 20;23(33):8469-76
pubmed: 16293877
Radiology. 2017 May;283(2):361-370
pubmed: 28221097
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
J Magn Reson Imaging. 2019 Aug;50(2):377-390
pubmed: 30659696
Breast Cancer Res. 2013 Jun 20;15(3):R48
pubmed: 23786804
J Clin Oncol. 2007 Jan 1;25(1):118-45
pubmed: 17159189
J Clin Oncol. 2009 Dec 20;27(36):6124-8
pubmed: 19884532
J Clin Oncol. 2010 Jun 1;28(16):2784-95
pubmed: 20404251
J Natl Cancer Inst. 2016 Jan 07;108(3):
pubmed: 26744477
Lancet. 2005 May 21-27;365(9473):1769-78
pubmed: 15910949
Int J Cancer. 2015 Oct 1;137(7):1729-38
pubmed: 25820931
Lancet. 2016 Jan 23;387(10016):341-348
pubmed: 26547101
J Clin Oncol. 2015 Apr 1;33(10):1128-35
pubmed: 25713430
Radiology. 2011 Nov;261(2):414-20
pubmed: 21900617
JAMA Oncol. 2017 Nov 1;3(11):1495-1502
pubmed: 28655029
J Am Coll Radiol. 2013 Jan;10(1):11-4
pubmed: 23290667
N Engl J Med. 2004 Jul 29;351(5):427-37
pubmed: 15282350
Breast Cancer Res Treat. 2014 Jun;145(3):663-72
pubmed: 24687378
J Natl Cancer Inst. 1999 Dec 1;91(23):2020-8
pubmed: 10580027
J Natl Cancer Inst. 2005 Aug 17;97(16):1195-203
pubmed: 16106024
CA Cancer J Clin. 2007 Mar-Apr;57(2):75-89
pubmed: 17392385
N Engl J Med. 2007 Jan 18;356(3):227-36
pubmed: 17229950
J Clin Oncol. 2011 May 1;29(13):1664-9
pubmed: 21444874
J Natl Compr Canc Netw. 2009 Nov;7(10):1060-96
pubmed: 19930975
JAMA. 2004 Sep 15;292(11):1317-25
pubmed: 15367553
JAMA. 2015 Oct 20;314(15):1615-34
pubmed: 26501537
JAMA. 2012 Apr 4;307(13):1394-404
pubmed: 22474203
Ann Intern Med. 2016 Feb 16;164(4):279-96
pubmed: 26757170
JAMA. 2015 Oct 20;314(15):1599-614
pubmed: 26501536
J Clin Oncol. 2010 Mar 20;28(9):1450-7
pubmed: 20177029
N Engl J Med. 2005 Oct 27;353(17):1784-92
pubmed: 16251534